Pharma Journalist -

Ironwood Pharmaceuticals, Inc., a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced…
Read More...

Bristol Myers Squibb announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New York Heart Association (NYHA) class…
Read More...

Valneva SE, a specialty vaccine company announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine IXCHIQ for the…
Read More...

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA)…
Read More...

Biopharmaceutical company Cingulate Inc. has been awarded a $3 million grant from a private foundation to accelerate the development of its once-daily anxiety treatment, CTx-2103…
Read More...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has received approval from the U.S. Food and Drug Administration (FDA) for its cancer treatment biosimilar, Jobevne…
Read More...

The U.S. Food and Drug Administration (FDA) has announced a significant shift in drug development, aiming to replace animal testing with more effective, human-relevant methods. This…
Read More...

Renovaro Biosciences Inc., a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, announced it closed its previously…
Read More...

Epsilogen announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company developing engineered immunoglobulin A (IgA) antibodies, to create the world’s leading…
Read More...

ALX Oncology Holdings Inc., announced receipt of U.S. Food and Drug Administration (FDA) clearance for the Investigational New Drug (IND) application for ALX2004, the company’s…
Read More...